Le Lézard
Classified in: Health, Science and technology
Subjects: HEALTH, MISCELLANEOUS

Philips showcases world's first mobile MRI system with helium-free operations at #RSNA23


November 26, 2023

BlueSeal MR Mobile's unique magnet technology advances patient outcomes and access to care with high quality diagnostic imaging and enhanced workflows

Amsterdam, the Netherlands and Chicago, USA ? Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today showcases the world's first mobile MRI system with helium-free operations at #RSNA23. BlueSeal MR Mobile [1], the industry's first and only 1.5T fully sealed magnet, delivers patient-centric MRI services where and whenever needed. Unlike other mobile MRI scanners, the BlueSeal MR Mobile is more agile and lightweight so it can be located in more convenient places for patients, like near a hospital's main entrance.

The first BlueSeal MR Mobile unit, developed for outpatient radiology and oncology solutions provider Akumin, will debut on the show floor at #RSNA23. With more than 600 systems installed globally, the MRI scanners are equipped with Philips' BlueSeal magnet technology that saved more than 1.5 million liters of helium since 2018. The extension of this breakthrough technology in a mobile unit means Philips will be able to expand quality access to MRI exams for more patients in more places, in a more sustainable way with helium-free operations.

"Philips is partnering with healthcare systems to help them tackle resource constraints and continued increases in patient volumes, and having access to mobile MRI scanners is a real game-changer for remote and rural communities around the world. By introducing our breakthrough technology into the mobile MR market, we are significantly reducing the operational and sustainability issues associated with conventional scanners and helping healthcare providers to deliver fast, patient-friendly quality of care," said Ruud Zwerink, General Manager Magnetic Resonance at Philips.

Unlike conventional MRI magnets, which typically require around 1,500 liters of liquid helium, a Philips BlueSeal magnet only needs to be pre-loaded with 7 liters, providing a major advantage in terms of up-time and costs. BlueSeal MR Mobile can also connect  to Philips Radiology Operations Command Center (ROCC) a multi-vendor, multi-modality, virtual imaging solution, which securely connects technologists with remote imaging experts in real-time using audio, video, and peer-to-peer text chat capabilities. 

For more information on Philips' new portfolio of mobile MRI scanners and Philips Radiology Operations Command Center, visit Philips at RSNA 2023 (Booth #6730) and follow @PhilipsLiveFrom for #RSNA23 updates throughout the event.

[1] This product is not yet CE marked, and not yet available for sale in Europe. Available only in the U.S. market.

For further information, please contact:

Kathy O'Reilly
Philips Global Press Office
Tel.: +1 978 221 8919
E-Mail: [email protected]

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 71,500 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments



These press releases may also interest you

at 07:10
bluebird bio, Inc. announced today that it will host a conference call to discuss first quarter 2024 results and business updates on May 9, at 8:00 a.m. ET. To participate in the conference call, please dial +1 (800) 715-9871 (U.S. and Canada) and...

at 07:05
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it received a Notice of Allowance from the European Patent Office for its...

at 07:05
Stoke Therapeutics, Inc. , a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today reported financial results for the first quarter of 2024 and...

at 07:05
bluebird bio, Inc. announced today that it has completed the first commercial cell collection for LYFGENIA (lovotibeglogene autotemcel), a one-time gene therapy for the treatment of sickle cell disease in patients with a history of vaso-occlusive...

at 07:05
Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that it has entered into an exclusive...

at 07:01
Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced its participation in the 27th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, May 7-11, in Baltimore, MD. Ginkgo will...



News published on and distributed by: